Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.

Pietsch T, Schmidt R, Remke M, Korshunov A, Hovestadt V, Jones DT, Felsberg J, Kaulich K, Goschzik T, Kool M, Northcott PA, von Hoff K, von Bueren AO, Friedrich C, Mynarek M, Skladny H, Fleischhack G, Taylor MD, Cremer F, Lichter P, Faldum A, Reifenberger G, Rutkowski S, Pfister SM.

Acta Neuropathol. 2014 Jul;128(1):137-49. doi: 10.1007/s00401-014-1276-0. Epub 2014 May 4.

PMID:
24791927
[PubMed - in process]
Free PMC Article
2.

G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.

Whittier KL, Boese EA, Gibson-Corley KN, Kirby PA, Darbro BW, Qian Q, Ingram WJ, Robertson T, Remke M, Taylor MD, O'Dorisio MS.

Acta Neuropathol Commun. 2013 Oct 10;1(1):66. doi: 10.1186/2051-5960-1-66.

PMID:
24252460
[PubMed]
Free PMC Article
3.

BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.

Henssen A, Thor T, Odersky A, Heukamp L, El-Hindy N, Beckers A, Speleman F, Althoff K, Schäfers S, Schramm A, Sure U, Fleischhack G, Eggert A, Schulte JH.

Oncotarget. 2013 Nov;4(11):2080-95.

PMID:
24231268
[PubMed - in process]
Free PMC Article
4.

ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma.

Ingram WJ, Crowther LM, Little EB, Freeman R, Harliwong I, Veleva D, Hassall TE, Remke M, Taylor MD, Hallahan AR.

Exp Hematol Oncol. 2013 Oct 4;2(1):26. doi: 10.1186/2162-3619-2-26.

PMID:
24219920
[PubMed]
Free PMC Article
5.

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.

Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, Luu B, Jones DT, Garzia L, Dubuc AM, Zhukova N, Vanner R, Kros JM, French PJ, Van Meir EG, Vibhakar R, Zitterbart K, Chan JA, Bognár L, Klekner A, Lach B, Jung S, Saad AG, Liau LM, Albrecht S, Zollo M, Cooper MK, Thompson RC, Delattre OO, Bourdeaut F, Doz FF, Garami M, Hauser P, Carlotti CG, Van Meter TE, Massimi L, Fults D, Pomeroy SL, Kumabe T, Ra YS, Leonard JR, Elbabaa SK, Mora J, Rubin JB, Cho YJ, McLendon RE, Bigner DD, Eberhart CG, Fouladi M, Wechsler-Reya RJ, Faria CC, Croul SE, Huang A, Bouffet E, Hawkins CE, Dirks PB, Weiss WA, Schüller U, Pollack IF, Rutkowski S, Meyronet D, Jouvet A, Fèvre-Montange M, Jabado N, Perek-Polnik M, Grajkowska WA, Kim SK, Rutka JT, Malkin D, Tabori U, Pfister SM, Korshunov A, von Deimling A, Taylor MD.

Acta Neuropathol. 2013 Dec;126(6):917-29. doi: 10.1007/s00401-013-1198-2. Epub 2013 Oct 31.

PMID:
24174164
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Update on molecular and genetic alterations in adult medulloblastoma.

Kool M, Korshunov A, Pfister SM.

Memo. 2012 Sep;5(3):228-232. Epub 2012 Jul 20.

PMID:
23864912
[PubMed]
Free PMC Article
7.

Signaling pathway and molecular subgroups of medulloblastoma.

Li KK, Lau KM, Ng HK.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1211-22. Print 2013. Review.

PMID:
23826403
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.

Brown AP, Barney CL, Grosshans DR, McAleer MF, de Groot JF, Puduvalli VK, Tucker SL, Crawford CN, Khan M, Khatua S, Gilbert MR, Brown PD, Mahajan A.

Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):277-84. doi: 10.1016/j.ijrobp.2013.01.014. Epub 2013 Feb 20.

PMID:
23433794
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Medulloblastomics: the end of the beginning.

Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ, Pomeroy SL, Korshunov A, Lichter P, Taylor MD, Pfister SM.

Nat Rev Cancer. 2012 Dec;12(12):818-34. doi: 10.1038/nrc3410. Review.

PMID:
23175120
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Molecular markers in pediatric neuro-oncology.

Ichimura K, Nishikawa R, Matsutani M.

Neuro Oncol. 2012 Sep;14 Suppl 4:iv90-9. doi: 10.1093/neuonc/nos204. Review.

PMID:
23095836
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

What underlies the diversity of brain tumors?

Swartling FJ, Hede SM, Weiss WA.

Cancer Metastasis Rev. 2013 Jun;32(1-2):5-24. doi: 10.1007/s10555-012-9407-3. Review.

PMID:
23085857
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.

Vo DT, Subramaniam D, Remke M, Burton TL, Uren PJ, Gelfond JA, de Sousa Abreu R, Burns SC, Qiao M, Suresh U, Korshunov A, Dubuc AM, Northcott PA, Smith AD, Pfister SM, Taylor MD, Janga SC, Anant S, Vogel C, Penalva LO.

Am J Pathol. 2012 Nov;181(5):1762-72. doi: 10.1016/j.ajpath.2012.07.031. Epub 2012 Sep 14.

PMID:
22985791
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.

Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, Ramos AH, Ross MG, Russ C, Shefler E, Sivachenko A, Sogoloff B, Stojanov P, Tamayo P, Mesirov JP, Amani V, Teider N, Sengupta S, Francois JP, Northcott PA, Taylor MD, Yu F, Crabtree GR, Kautzman AG, Gabriel SB, Getz G, Jäger N, Jones DT, Lichter P, Pfister SM, Roberts TM, Meyerson M, Pomeroy SL, Cho YJ.

Nature. 2012 Aug 2;488(7409):106-10. doi: 10.1038/nature11329.

PMID:
22820256
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.

Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, Clifford SC, Pietsch T, von Bueren AO, Rutkowski S, McCabe M, Collins VP, Bäcklund ML, Haberler C, Bourdeaut F, Delattre O, Doz F, Ellison DW, Gilbertson RJ, Pomeroy SL, Taylor MD, Lichter P, Pfister SM.

Acta Neuropathol. 2012 Apr;123(4):473-84. doi: 10.1007/s00401-012-0958-8. Epub 2012 Feb 23.

PMID:
22358457
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

An animal model of MYC-driven medulloblastoma.

Pei Y, Moore CE, Wang J, Tewari AK, Eroshkin A, Cho YJ, Witt H, Korshunov A, Read TA, Sun JL, Schmitt EM, Miller CR, Buckley AF, McLendon RE, Westbrook TF, Northcott PA, Taylor MD, Pfister SM, Febbo PG, Wechsler-Reya RJ.

Cancer Cell. 2012 Feb 14;21(2):155-67. doi: 10.1016/j.ccr.2011.12.021.

PMID:
22340590
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The molecular classification of medulloblastoma: driving the next generation clinical trials.

Leary SE, Olson JM.

Curr Opin Pediatr. 2012 Feb;24(1):33-9. doi: 10.1097/MOP.0b013e32834ec106. Review.

PMID:
22189395
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Molecular subgroups of medulloblastoma: the current consensus.

Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM.

Acta Neuropathol. 2012 Apr;123(4):465-72. doi: 10.1007/s00401-011-0922-z. Epub 2011 Dec 2.

PMID:
22134537
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk